2013
DOI: 10.1080/00015458.2013.11680954
|View full text |Cite
|
Sign up to set email alerts
|

Protective Effect of Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist, against Intestinal Ischemia-Reperfusion Injury in the Rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 31 publications
0
5
0
Order By: Relevance
“…1517 Additionally, animal studies show that montelukast has a beneficial effect on oxidative stress-mediated conditions, such as ischemia-reperfusion injury, drug intoxication, and lipopolysaccharide-induced oxidative stress. 1821 Al Saadi reports that montelukast decreases ROS production in whole blood and isolates human polymorphonuclear neutrophils in asthmatic children. 22 However, our recent study showed that montelukast monotherapy does not overcome the oxidative stress produced by asthma in children.…”
Section: Discussionmentioning
confidence: 99%
“…1517 Additionally, animal studies show that montelukast has a beneficial effect on oxidative stress-mediated conditions, such as ischemia-reperfusion injury, drug intoxication, and lipopolysaccharide-induced oxidative stress. 1821 Al Saadi reports that montelukast decreases ROS production in whole blood and isolates human polymorphonuclear neutrophils in asthmatic children. 22 However, our recent study showed that montelukast monotherapy does not overcome the oxidative stress produced by asthma in children.…”
Section: Discussionmentioning
confidence: 99%
“…GSH has been used to indicate antioxidant systems in evaluating various substances in such an ischemia/reperfusion model. [ 27 ] As in the study of Buetler et al, increased GSH levels were elevated as a defense mechanism against increased free oxygen radicals. [ 10 ]…”
Section: Discussionmentioning
confidence: 94%
“…In fact, the tight correlation between the decreases of intestinal GSH content and the duration of ischemia only 5 min after the initiation of reperfusion (Figure 3) provides a very interesting clue to the role of this cellular antioxidant during intestinal I/R. Other authors have reported significant decreases in intestinal GSH after 30 min ischemia and 45 min reperfusion of only 18% of the control value [17], or a 30 % reduction in total antioxidant capacity (GSH is part of this capacity) after 1 h of ischemia followed by 2 h of reperfusion [18], or have only measured the blood GSH concentration without caring about the concentration in cecum [19]. As can be interpreted by the data herein, the modifications of intestinal GSH content occurred immediately after initiating reperfusion (as soon as 5 min) and were proportional to the duration of ischemia.…”
Section: Discussionmentioning
confidence: 99%